MedTrace Logo

Validation of the Turkish Translation of the London Speech Evaluation Scale

NCT04690166 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2021-07-29

No results posted yet for this study

Summary

Purpose of the study is the validation and cultual adaptation of the Turkish translation of the London Speech Evaluation Scale (LSE-T), so that it would be used as an assessment tool for Turkish head and neck cancer patients. There is no validated Turkish version of LSE to measure severity of perceptual speech in head and neck cancer patients.

Conditions

Interventions

OTHER

The speech records related to the reading document

The document consists "bit, bet, but" words and Diyet passage. Volunteers will read the document in front of the microphone and also the speech will recorded by a computer.

Sponsors & Collaborators

  • Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization

    lead OTHER

Principal Investigators

  • Ziya Salturk, Asso Prof,MD · Anadolu Medical Center, In Affiliation with Johns Hopkins Medicine

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-12-21
Primary Completion
2021-05-21
Completion
2021-05-21

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04690166 on ClinicalTrials.gov